HealthPhoto: Firstpost BusinessDr Reddy's Gets US Approval for $40 Generic HIV Prevention Shot
Dr. Reddy's Laboratories, an Indian pharmaceutical company, received tentative US FDA approval for its generic version of lenacapavir, an injectable HIV prevention drug administered twice a year. The drug will be priced at $40 per person annually and made available across 120 low- and middle-income countries. Originally developed by Gilead Sciences, lenacapavir is over 99.9% effective in preventing HIV infection.
Firstpost Business·




